RUNX3 and neoplasm: Meanwhile, Runx3 suppresses the expression of T‐bet [56] and Eomes, as well as KLF2, and downregulates tissue‐egress molecules including S1PR1, CD62L and CCR7 [59], further facilitating the retention of CD8+TRM cells within the tumor microenvironment (TME).